Trials / Active Not Recruiting
Active Not RecruitingNCT01678872
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Oxford BioMedica · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the long term safety of an experimental gene transfer agent, RetinoStat®, designed to treat neovascular age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RetinoStat | Long Term Follow up of patients who received RetinoStat in a previous study |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2029-03-01
- Completion
- 2029-03-01
- First posted
- 2012-09-05
- Last updated
- 2026-01-14
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01678872. Inclusion in this directory is not an endorsement.